Opening Plenary Presidential Session

26th November – 12:15 – 13:15
Education Track

“Forward as one – Europe as a Global Player”

Whether it is post-Brexit growth in the UK or resilience in China, improved healthcare supports economic activity.

A healthier Europe will mean citizens spending less and less time in hospitals under expensive treatment regimes, often at a direct cost to the taxpayer, and it will also mean that people receiving the right treatment at the right time are more able to stay in the workplace, thus generating wealth rather than whittling it away.

A shift towards preventative medicine will reduce costs still further. A focus on research into new medicines and cutting-edge treatments will also create jobs – whether they be in research itself, education, design and manufacture of in-vitro products or within the pharmaceutical industry.

If Europe is in the vanguard of developing new ways of keeping citizens healthy, it will inevitably attract investment from outside of the bloc.

The road to better health must have personalised medicine as its destination. This innovative method of treating patients utilises research, data and up-to-the-minute technology to provide better diagnostics and follow-up for citizens than is currently the case.

With the backing of the European Union, Europe can work towards building a healthy and wealthy Europe, one worthy of its stated goals for generations to come.

Chair

Denis Horgan

Denis Horgan

Executive Director, European Alliance for Personalised Medicine

Panel

Minister Marcin Czech

Minister Marcin Czech

Undersecretary of State/Vice Minister at Ministry of Health Poland

Walter Ricciardi

Walter Ricciardi

President, Italian National Institute of Health (Istituto Superiore di Sanità)

Christine Chomienne

Christine Chomienne

Director of Research & Innovation, INCa, France

Michael Zaiac

Michael Zaiac

Head of Medical Affairs, Oncology Region Europe, Novartis